Aclaris Therapeutics to Participate in Two November Healthcare Investor Conferences

Rhea-AI Summary

Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced participation in two healthcare investor conferences in November 2022. On November 16, at 5:00 PM GMT/12:00 PM EST, Dr. Neal Walker, CEO, will engage in a fireside chat at the Jefferies London Healthcare Conference.

Additionally, on November 29 at 9:30 AM EST, he will participate in another fireside chat at the 34th Annual Piper Sandler Healthcare Conference in New York. Webcasts for both events will be available on Aclaris' website and archived for 30 days.

WAYNE, Pa., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that the company will participate in two November healthcare investor conferences.

On Wednesday, November 16, 2022 at 5:00 PM GMT/12:00 PM EST, Dr. Neal Walker, CEO of Aclaris, will participate in a fireside chat at the Jefferies London Healthcare Conference in London, UK.

On Tuesday, November 29, 2022 at 9:30 AM EST, Dr. Walker will also be participating in a fireside chat at the 34^th Annual Piper Sandler Healthcare Conference in New York, NY.

A webcast of these fireside chats may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcasts will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Therapeutics Contact:

Robert A. Doody Jr.
Vice President, Investor Relations
484-639-7235
rdoody@aclaristx.com

FAQ

When will Aclaris participate in investor conferences?

Aclaris will participate in investor conferences on November 16 and November 29, 2022.

Who is the CEO of Aclaris Therapeutics?

The CEO of Aclaris Therapeutics is Dr. Neal Walker.

What is the schedule for Aclaris' fireside chats?

The fireside chat at the Jefferies London Healthcare Conference is on November 16 at 5:00 PM GMT, and the chat at the Piper Sandler Healthcare Conference is on November 29 at 9:30 AM EST.

Where can I access the webcasts of Aclaris' events?

The webcasts can be accessed through the 'Events' page in the 'Investors' section of Aclaris' website.

How long will the webcasts from Aclaris' conferences be available?

The webcasts will be archived on Aclaris' website for at least 30 days.